Stonehage Fleming Financial Services Holdings LTD Oramed Pharmaceuticals Inc. Transaction History

Stonehage Fleming Financial Services Holdings LTD

$2.06 Billion
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2019 Oct 11, 2019	SELL	$2.95 - $3.64 $226,881 - $279,948	-76,909 Closed	0 $0
Q4 2018 Oct 11, 2019	BUY	$3.0 - $4.94 $230,727 - $379,930	76,909 New	76,909 $231,000

Others Institutions Holding ORMP

# of Institutions

Shares Held

5.69M

Call Options Held

8.3K

Put Options Held

2.7K

Murchinson Ltd. Toronto, A6

1.38M
Shares

$3.56 Million
0.36% of portfolio
Bml Capital Management, LLC Zionsville, IN

844K
Shares

$2.18 Million
1.65% of portfolio
Boothbay Fund Management, LLC New York, NY

690K
Shares

$1.78 Million
0.05% of portfolio
Morgan Jess S & CO Inc

366K
Shares

$945,314
2.07% of portfolio
Susquehanna International Group, LLP Bala Cynwyd, PA

344K
Shares

$888,650
0.0% of portfolio

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $100M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonehage Fleming Financial Services Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Stonehage Fleming Financial Services Holdings LTD with notifications on news.

Account